These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2020 related items for PubMed ID: 22236411

  • 1. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
    Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL.
    BMJ; 2012 Jan 10; 344():d7771. PubMed ID: 22236411
    [Abstract] [Full Text] [Related]

  • 2. Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis.
    Sun F, Chai S, Li L, Yu K, Yang Z, Wu S, Zhang Y, Ji L, Zhan S.
    J Diabetes Res; 2015 Jan 10; 2015():157201. PubMed ID: 25688373
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Pinelli NR, Hurren KM.
    Ann Pharmacother; 2011 Jul 10; 45(7-8):850-60. PubMed ID: 21730278
    [Abstract] [Full Text] [Related]

  • 4. Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Zhang F, Tong Y, Su N, Li Y, Tang L, Huang L, Tong N.
    J Diabetes; 2015 May 10; 7(3):329-39. PubMed ID: 25043423
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
    Hayes MR, Kanoski SE, Alhadeff AL, Grill HJ.
    Obesity (Silver Spring); 2011 Jul 10; 19(7):1342-9. PubMed ID: 21415845
    [Abstract] [Full Text] [Related]

  • 6. Glucagon-like peptide-1 receptor agonists for weight loss in adult patients without diabetes.
    Ottney A.
    Am J Health Syst Pharm; 2013 Dec 01; 70(23):2097-103. PubMed ID: 24249759
    [Abstract] [Full Text] [Related]

  • 7. Emerging GLP-1 receptor agonists.
    Lund A, Knop FK, Vilsbøll T.
    Expert Opin Emerg Drugs; 2011 Dec 01; 16(4):607-18. PubMed ID: 21905764
    [Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide-1 agonists.
    Padwal R.
    BMJ; 2012 Jan 10; 344():d7282. PubMed ID: 22236410
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
    Wang B, Zhong J, Lin H, Zhao Z, Yan Z, He H, Ni Y, Liu D, Zhu Z.
    Diabetes Obes Metab; 2013 Aug 10; 15(8):737-49. PubMed ID: 23433305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results.
    Madsbad S.
    Best Pract Res Clin Endocrinol Metab; 2009 Aug 10; 23(4):463-77. PubMed ID: 19748064
    [Abstract] [Full Text] [Related]

  • 18. Utility of GLP-1R agonists in diabetes requires long term study.
    de Oliveira JM.
    BMJ; 2012 Feb 28; 344():e1451; author reply e1459. PubMed ID: 22374904
    [No Abstract] [Full Text] [Related]

  • 19. Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.
    Tonneijck L, Muskiet MHA, Smits MM, Bjornstad P, Kramer MHH, Diamant M, Hoorn EJ, Joles JA, van Raalte DH.
    Diabetes Obes Metab; 2018 May 28; 20(5):1235-1245. PubMed ID: 29341461
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide analogues for type 2 diabetes mellitus.
    Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A.
    Cochrane Database Syst Rev; 2011 Oct 05; 2011(10):CD006423. PubMed ID: 21975753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 101.